Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AVBP compared with CMPX: revenue, margins and what each company keeps, and the suppliers and customers both name
AVBP
ArriVent BioPharma, Inc.
Change
Mkt cap
Revenue
Revenue
CMPX
Compass Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AVBP
ArriVent BioPharma, Inc.
vs
CMPX
Compass Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
AVBP: latest quarter not drawable. CMPX: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AVBP
8
—
Shanghai Allist Pharmaceuticals
unlisted
supplier
—
Lepu Biopharma
unlisted
supplier
—
Aarvik Therapeutics
unlisted
supplier
—
Jiangsu Alphamab Biopharmaceuticals
unlisted
supplier
4 more · AVBP chain
›
Shared
0
No shared counterparties.
Only CMPX
5
—
ABL Bio
unlisted
supplier
—
Adimab
unlisted
supplier
—
B. Riley Securities
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
Elpiscience Biopharmaceuticals
unlisted
supplier
1 more · CMPX chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AVBP, solid
CMPX, dashed
AVBP
ArriVent BioPharma, Inc.
Change
14.93
▼
−6.41%
· post 14.72
Mkt cap
$707.9M
Revenue
—
CMPX
Compass Therapeutics, Inc.
Change
0.79
▲
+3.85%
· post 0.79
Closed
Oct 30 '26
Mkt cap
$141.6M
Revenue
$850,000
Q2 FY24
vs
Compare
Closed
Oct 30 '26
AVBP
ArriVent BioPharma, Inc.
vs
CMPX
Compass Therapeutics, Inc.
14.93
▼
−6.41%
post 14.72
Price
0.79
▲
+3.85%
post 0.79
$707.9M
Mkt cap
$141.6M
—
Revenue
$850,000
Q2 FY24
Change
Change
AVBP
14.93
▼
−6.41%
vs
CMPX
0.79
▲
+3.85%
Closed
Oct 30 '26